{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:03:36Z","timestamp":1763125416151,"version":"3.45.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>A 60-year-old man was admitted to the Department of Neurology presenting with general malaise, myoclonus, bladder dysfunction, and weight loss. Examination revealed hyperreflexia, and cerebrospinal fluid analysis demonstrated pleocytosis and elevated total protein. The initial MRI did not reveal apparent abnormalities. The differential diagnosis included autoimmune disorders, malignancy, or infection. FDG-PET\/CT, performed to exclude malignancy, only showed increased spinal cord activity. Laboratory tests ruled out most infections, and the patient received 1000\u00a0mg methylprednisolone for suspected autoimmune disease. The diagnosis of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy was confirmed by anti-GFAP antibodies detected in an academic laboratory.<\/jats:p>","DOI":"10.1097\/rlu.0000000000006076","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:00:56Z","timestamp":1763125256000},"page":"1183-1185","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal FDG Uptake in the Spinal Cord in Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy"],"prefix":"10.1097","volume":"50","author":[{"given":"Friso M.","family":"van der Zant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00eblle M.E.","family":"van Assema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco J.J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"R1-20251114","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/MNM.0000000000001188","article-title":"Physiological fluorodeoxyglucose uptake of spinal cord in adults","volume":"41","author":"Guner","year":"2020","journal-title":"Nucl Med Commun"},{"key":"R2-20251114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13550-020-00680-8","article-title":"[18F]FDG uptake of the normal spinal cord in PET\/MR imaging: comparison with PET\/CT imaging","volume":"10","author":"Aiello","year":"2020","journal-title":"EJNMMI Res"},{"key":"R3-20251114","first-page":"317","article-title":"The normal variant (18)F FDG uptake in the lower thoracic spinal cord segments in cancer patients without CNS malignancy","volume":"3","author":"Bhatt","year":"2013","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R4-20251114","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00259-017-3735-z","article-title":"Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder","volume":"44","author":"Higashiyama","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20251114","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"R6-20251114","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature","volume":"9","author":"Shan","year":"2018","journal-title":"Front Immunol"},{"key":"R7-20251114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune GFAP astrocytopathy","volume":"332","author":"Kimura","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R8-20251114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000479948","article-title":"Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases","volume":"24","author":"Yang","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"R9-20251114","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1\u202fyear","volume":"321","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:00:58Z","timestamp":1763125258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006076","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"2025-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}